Companies / JNJ vs VTRS
JNJ vs VTRS: Johnson & Johnson and Viatris
Johnson & Johnson (JNJ) reported $94.2B in revenue against a 28.5% net margin, while Viatris (VTRS) reported $14.3B at a -24.6% net margin, most recently.
| Metric | JNJ | VTRS |
|---|---|---|
| Revenue | $94.2B | $14.3B |
| Net Income | $26.8B | $-3.5B |
| Gross Margin | 67.9% | 35.1% |
| Operating Margin | — | -18.6% |
| EPS (Diluted) | $11.03 | $-3.00 |
| Free Cash Flow | $19.7B | $1.9B |
| Total Debt | $49.9B | $14.4B |
| P/E Ratio | 18.8× | n/m |
| P/B Ratio | n/m | n/m |
| Stock Price | $272.48 | $19.00 |
Free: last 5 years
| Fiscal year | FY2018 🔒 | FY2019 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| JNJ Revenue | ••••• | ••••• | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B |
| VTRS Revenue | ••••• | ••••• | $17.9B | $16.3B | $15.4B | $14.7B | $14.3B |